Thomas Perone
Compliance Officer chez OVID THERAPEUTICS INC.
Fortune : 38 697 $ au 30/04/2024
Postes actifs de Thomas Perone
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OVID THERAPEUTICS INC. | Compliance Officer | - | - |
| Conseiller Juridique Général | 21/03/2019 | - | |
| Secrétaire Général | 21/03/2019 | - |
Historique de carrière de Thomas Perone
Anciens postes connus de Thomas Perone
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CELGENE | Conseiller Juridique Général | 01/04/2006 | - |
| Secrétaire Général | 01/06/2014 | 01/05/2018 | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Conseiller Juridique Général | 01/12/2001 | 01/04/2006 |
| Proskauer Rose LLC | Corporate Officer/Principal | - | - |
Formation de Thomas Perone
| Rutgers State University of New Jersey | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
| Seton Hall University School of Law | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| France | 2 |
Opérationnelle
| General Counsel | 3 |
| Corporate Secretary | 2 |
| Compliance Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OVID THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
| Proskauer Rose LLC |
- Bourse
- Insiders
- Thomas Perone
- Expérience
